FDA Compounded Peptide Update

FDA / PCAC — official records & coverage — FDA Compounded Peptide Update

Channel: Redline Compounding Pharmacy · Our label: Government proceedings and coverage of them · Source: youtube.com/watch?v=uqvQ9i-fbUk

What this video covers

If you’re a clinician, a patient, or simply following the recent headlines in the wellness space, you’ve likely heard that the regulatory landscape for peptides is shifting. I’m Tim, pharmacist with Redline Compounding Pharmacy, and we are getting a lot of questions on this, so I wanted to give you an update on what’s actually happening. Following recent statements from HHS Secretary RFK Jr., the FDA has issued a formal notice that moves several high-interest peptides into a new phase of regulatory review. Many believe this action is to rein in the…

Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.

Key points, in the speaker’s own framing

• Compounds like BPC-157 and TB-500 are often studied for wound healing and tissue repair.
• Because peptides influence biological signaling, the FDA monitors them closely for immunogenicity, which is the risk of an immune response, and impurities.
• On July 23rd, the committee will review BPC-157, KPV, TB-500, and MOTS-c.
• Furthermore, the FDA has already slated a second review for February 2027 to address five additional compounds, including GHK-Cu and melanotan II.
• Federal law requires that bulk substances used in compounding come from FDA-registered facilities and meet pharmaceutical grade standards.
• The bottom line, the era of unregulated gray market peptides may be coming to an end, but the era of fully regulated compounded peptide therapy is just beginning its formal journey.

Read next

• BPC-157 — compound page
• TB-500 — compound page
• MOTS-c — compound page
• Epitalon — compound page
• KPV — compound page
• GHK-Cu — more videos
• Semaglutide — more videos
• Tirzepatide — more videos
• Melanotan — more videos
• DSIP — more videos
• All videos from this channel

Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.